Log in to search using one of your social media accounts:

 

EmeTerm Anti-Nausea and Vomiting Wristband is FDA Cleared
VANCOUVER, British Columbia, May 21, 2018 -- (Healthcare Sales & Marketing Network) -- WAT Medical's leading product to treat nausea-induced vomiting, EmeTerm, has received its FDA clearance earlier in April. Now ready to officially enter the U.S. market ... Devices, Neurology, Product Launch WAT Medical Enterprise, EmeTerm, neuromodulation, nausea (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - May 21, 2018 Category: Pharmaceuticals Source Type: news

CERENOVUS Receives FDA Clearance For Next Generation Stent Retriever Device Used To Treat Ischemic Stroke
EMBOTRAP II Revascularization Device Captures and Removes Life-threatening Blood Clots, Rapidly Restores Blood Flow IRVINE, Calif., May 21, 2018 -- (Healthcare Sales & Marketing Network) -- CERENOVUS, part of the Johnson & Johnson Medical Devices Compa... Devices, Interventional, Radiology, Neurology, FDA CERENOVUS, Johnson & Johnson, EMBOTRAP, Revascularization, thrombectomy (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - May 21, 2018 Category: Pharmaceuticals Source Type: news

Nestlé Skin Health Announces the FDA Approval of Restylane(R) Lyft for Hands, the First and Only Hyaluronic Acid (HA) Dermal Filler for Use in the Back of Hands
New Survey Shows Nearly Two out of Three Women Believe Their Hands Make Them Look Older than Their Age1† FORT WORTH, Texas, May 21, 2018 -- (Healthcare Sales & Marketing Network) -- Nestlé Skin Health, a global leader focused on meeting the worl... Devices, Dermatology, FDA Nestlé Skin Health, Restylane Lyft, Restylane, dermal filler (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - May 21, 2018 Category: Pharmaceuticals Source Type: news

Apexigen Expands Leadership Team With Appointment Of Frances Rena Bahjat, Ph.D. Vice President, Discovery Research
SAN CARLOS, Calif., May 18, 2018 -- (Healthcare Sales & Marketing Network) -- Apexigen, Inc., a clinical-stage biopharmaceutical company, today announced the appointment of Frances Rena Bahjat, Ph.D. as Vice President, Discovery Research. In this newly-cr... Biopharmaceuticals, Oncology, Personnel Apexigen, APXiMAB (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - May 18, 2018 Category: Pharmaceuticals Source Type: news

FDA Approves Aimovig(TM) (erenumab-aooe), A Novel Treatment Developed Specifically For Migraine Prevention
Migraine is a Severe Neurologic Disease That Profoundly Impacts Millions of Patients in the United States Aimovig is the First and Only FDA-Approved Treatment to Block the Calcitonin Gene-Related Peptide Receptor (CGRP-R), Which Plays an Important Role ... Biopharmaceuticals, Devices, Drug Delivery, FDA Amgen, Aimovig, erenumab, migraine, SureClick, autoinjector (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - May 18, 2018 Category: Pharmaceuticals Source Type: news

Award-Winning Olympus Brings a "Full Circle" Urology Offering to AUA
EMPOWER Laser Portfolio Is Unveiled and Featured in Hands-On Session; New Line Features Full Range of Lithotripsy Modes Including Dusting, Stone Stabilization and Soft Tissue CENTER VALLEY, Pa., May 17, 2018 -- (Healthcare Sales & Marketing Network) --... Devices, Urology, Product Launch Olympus, Olympus Medical Systems, EMPOWER laser, Ho:YAG, lithotripsy (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - May 17, 2018 Category: Pharmaceuticals Source Type: news

Statement from FDA Commissioner Scott Gottlieb, M.D., on new agency efforts to shine light on situations where drug makers may be pursuing gaming tactics to delay generic competition
SILVER SPRING, Md., May 17, 2018 -- (Healthcare Sales & Marketing Network) -- No patients should be priced out of medicines they need to support their health. As stressed by the President and Secretary Azar last week, one of the Administration's highest pr... Biopharmaceuticals, Generics, FDA U.S. Food and Drug Administration (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - May 17, 2018 Category: Pharmaceuticals Source Type: news

Olympus Expands Its Endoscope Reprocessing Portfolio to Include ChanlDry Drying Cabinet, Endo SafeStack Transport Cart and Visual Reprocessing Guide
Expansion Underscores Olympus' Endoscope Protection and Infection Prevention for Device's Full Journey through Facility CENTER VALLEY, Pa., May 17, 2018 -- (Healthcare Sales & Marketing Network) -- Olympus, a global technology leader in designing and d... Devices, Product Launch Olympus, Olympus Medical Systems, ChanlDry, Drying Cabinet, endoscope (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - May 17, 2018 Category: Pharmaceuticals Source Type: news

ImaginAb Reconstitutes Scientific Advisory Board
Members include Immuno-Oncology leaders Dr. Antoni Ribas, Dr. Daniel D. Von Hoff and Dr. David Mankoff LOS ANGELES, May 17, 2018 -- (Healthcare Sales & Marketing Network) -- ImaginAb Inc., an immuno-oncology imaging company, today announced the reconst... Biopharmaceuticals, Oncology, Radiology, Personnel ImaginAb , minibodie, PET scan, ImmunoPET (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - May 17, 2018 Category: Pharmaceuticals Source Type: news

Correvio Announces Enrollment of First Patient in Phase 3 Study Evaluating Brinavess(R) in China
VANCOUVER, May 17, 2018 -- (Healthcare Sales & Marketing Network) - Correvio Pharma Corp. (NASDAQ: CRME / TSX: COM), formerly Cardiome Pharma Corp., today announced that its partner Eddingpharm has enrolled the first patient in a randomized, double-blind,... Biopharmaceuticals, Cardiology Correvio Pharma, Cardiome Pharma, Brinavess, atrial fibrillation (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - May 17, 2018 Category: Pharmaceuticals Source Type: news

FogPharma Secures $66 Million Series B Financing
Company is pioneering a powerful new class of medicines - cell-penetrating miniproteins - with an on-demand drug discovery platform for the treatment of serious diseases driven by intractable targets BOSTON, May 16, 2018 -- (Healthcare Sales & Marketing... Biopharmaceuticals, Venture Capital, Personnel FogPharma, miniprotein (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - May 16, 2018 Category: Pharmaceuticals Source Type: news

Photocure Announces Blue Light Cystoscopy with Cysview(R) Now Available for Surveillance of Bladder Cancer
OSLO, Norway, May 16, 2018 -- (Healthcare Sales & Marketing Network) -- Photocure ASA (OSE: PHO), May 16, 2018, announced today the launch of Blue Light Cystoscopy (BLC™) with Cysview for a new indication of surveillance cystoscopy of bladder cancer. ... Devices, Diagnostics, Oncology, Product Launch Photocure, Karl Storz, Blue Light Cystoscopy, Cysview, bladder cancer (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - May 16, 2018 Category: Pharmaceuticals Source Type: news

Eiger Announces Expanded License Agreement with Merck for Investigational Candidate Lonafarnib and Collaboration with The Progeria Research Foundation (PRF)
Plans to Seek FDA Guidance for Potential Hutchinson-Gilford Progeria Syndrome (HGPS or Progeria) Indication PALO ALTO, Calif., May 16, 2018 -- (Healthcare Sales & Marketing Network) -- Eiger BioPharmaceuticals, Inc. (NASDAQ: EIGR), focused on the devel... Biopharmaceuticals, Licensing, Distribution Eiger BioPharmaceuticals, Merck, Lonafarnib, Progeria Syndrome (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - May 16, 2018 Category: Pharmaceuticals Source Type: news

Protagonist Therapeutics Appoints Bryan Giraudo to Board of Directors
NEWARK, Calif., May 16, 2018 -- (Healthcare Sales & Marketing Network) -- Protagonist Therapeutics, Inc. (Nasdaq: PTGX) today announced the appointment of Bryan Giraudo to its Board of Directors. Mr. Giraudo currently serves as Chief Financial Officer of ... Biopharmaceuticals, Gastroenterology, Personnel Protagonist Therapeutics, inflammatory bowel disease (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - May 16, 2018 Category: Pharmaceuticals Source Type: news

Bionik Laboratories Announces Rental Agreement with Tallahassee Memorial HealthCare for InMotion Arm Robotic System
Company's rental program limits upfront expenditures for hospitals and provides them with greater financial flexibility and maximum ROI TORONTO and BOSTON, May 16, 2018 -- (Healthcare Sales & Marketing Network) -- Bionik Laboratories Corp. (OTCQB: BNKL... Devices Bionik Laboratories, stroke, InMotion Arm Therapy (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - May 16, 2018 Category: Pharmaceuticals Source Type: news

Roivant Expands Senior Leadership with Key Hires
Dr. Sam Azoulay, former SVP and Chief Medical Officer at Pfizer Essential Health, joins as Chief Medical Officer Adele Gulfo, former President and General Manager for US Primary Care at Pfizer, joins as Chief of Commercial Development BASEL, Switzerl... Biopharmaceuticals, Personnel Roivant Sciences, Myovant, Axovant, Urovant, Enzyvant, Dermavant (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - May 16, 2018 Category: Pharmaceuticals Source Type: news

EIP Pharma Secures $20.5 Million in Series B Financing
Proceeds to Support Continued Development of Neflamapimod for Alzheimer's Disease CAMBRIDGE, Mass., May 16, 2018 -- (Healthcare Sales & Marketing Network) -- EIP Pharma, a therapeutics company focused on CNS diseases, today announced the successful com... Biopharmaceuticals, Neurology, Venture Capital EIP Pharma, neflamapimod, p38 alpha, Alzheimer's disease (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - May 16, 2018 Category: Pharmaceuticals Source Type: news

TapImmune Creates Scientific Advisory Board to Support Clinical Development of Multi-Antigen Cell Therapy Platform
Welcomes Renowned Thought Leaders Dr. Malcolm Brenner, Dr. Helen Heslop, and Dr. Cliona Rooney JACKSONVILLE, Fla., May 16, 2018 -- (Healthcare Sales & Marketing Network) -- TapImmune Inc. (NASDAQ: TPIV), a clinical-stage immuno-oncology company, today ... Biopharmaceuticals, Oncology, Personnel TapImmune, Marker Therapeutics, immunotherapy (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - May 16, 2018 Category: Pharmaceuticals Source Type: news

Positive Phase 3 Trial of DUPIXENT(R) (dupilumab) in Adolescents with Inadequately Controlled Moderate-to-severe Atopic Dermatitis
U.S. regulatory submission for patients ages 12-17 planned for third quarter 2018 TARRYTOWN, N.Y. and PARIS, May 16, 2018 -- (Healthcare Sales & Marketing Network) -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) and Sanofi today announced that a pivo... Biopharmaceuticals, Dermatology Regeneron Pharmaceuticals, Sanofi, DUPIXENT, dupilumab, atopic dermatitis (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - May 16, 2018 Category: Pharmaceuticals Source Type: news

Medicinal Chemistry Leaders Drs. Phil Carpino and Mike Genin Form New Chemistry Team at Recursion Pharmaceuticals
SALT LAKE CITY, May 15, 2018 -- (Healthcare Sales & Marketing Network) -- Recursion Pharmaceuticals, a biotechnology company that combines artificial intelligence (AI), experimental biology, and automation to discover drugs at scale, today announced that ... Biopharmaceuticals, Personnel Recursion Pharmaceuticals (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - May 15, 2018 Category: Pharmaceuticals Source Type: news

BrainQ Technologies Raises $8.8 Million to Treat Neurodisorders With Artificial Intelligence
Financing included Norma Investments, OurCrowd.com, and Qure Ventures JERUSALEM, May 15, 2018 -- (Healthcare Sales & Marketing Network) -- BrainQ, developing Artificial Intelligence (AI) powered technologies to treat neurodisorders in innovative ways, ... Devices, Neurology, Venture Capital BrainQ Technologies (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - May 15, 2018 Category: Pharmaceuticals Source Type: news

Caliber Imaging and Diagnostics, Inc. Announces FDA 510(k) Clearance for its VIVASCOPE System
BOSTON, May 15, 2018 -- (Healthcare Sales & Marketing Network) -- Caliber Imaging & Diagnostics Inc. (Caliber I.D.) announced today that it has received 510(k) clearance from the Food and Drug Administration (FDA) for modifications to its VIVASCOPE® S... Devices, Dermatology, FDA Caliber Imaging & Diagnostics, VIVASCOPE (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - May 15, 2018 Category: Pharmaceuticals Source Type: news

Amneal Introduces First Generic for Mephyton(R) (Phytonadione) Tablets, 5mg
BRIDGEWATER, N.J., May 15, 2018 -- (Healthcare Sales & Marketing Network) -- Amneal Pharmaceuticals, Inc. (NYSE: AMRX) has launched Phytonadione Tablets, USP, 5 mg, the first AB-rated therapeutic equivalent for Mephyton®. The product is available in ... Biopharmaceuticals, Generics, Product Launch Amneal Pharmaceuticals, Mephyton, Phytonadione (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - May 15, 2018 Category: Pharmaceuticals Source Type: news

Surface Pharmaceuticals, Inc. Announces $20 Million Series A Financing from Flying L Partners
Investment will enable Surface to fund its development programs focused on FDA approval of its ocular disease drug candidates SAN DIEGO, and PLEASANTON, Calif., May 15, 2018 -- (Healthcare Sales & Marketing Network) -- Surface Pharmaceuticals, Inc., an... Biopharmaceuticals, Ophthalmology, Venture Capital Surface Pharmaceuticals, Imprimis Pharmaceuticals (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - May 15, 2018 Category: Pharmaceuticals Source Type: news

FDA Clears Expanded Claims for 'Superbug' Test
Xpert® Carba-R now FDA-cleared to aid clinicians in determining appropriate therapeutic strategy for pure colony specimens SUNNYVALE, Calif., May 15, 2018 -- (Healthcare Sales & Marketing Network) -- Cepheid today announced that it has received cle... Diagnostics, FDA Cepheid, Xpert Carba-R, carbapenemase-producing CRE (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - May 15, 2018 Category: Pharmaceuticals Source Type: news

Lilly's Galcanezumab Meets Primary Endpoint in Phase 3 Study Evaluating Galcanezumab for the Prevention of Episodic Cluster Headache
INDIANAPOLIS, May 15, 2018 -- (Healthcare Sales & Marketing Network) -- Eli Lilly and Company (NYSE: LLY) announced today that galcanezumab met its primary endpoint in a Phase 3 study of patients with episodic cluster headache, demonstrating statistically... Biopharmaceuticals, Neurology Eli Lilly, cluster headache, galcanezumab (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - May 15, 2018 Category: Pharmaceuticals Source Type: news

Ansun BioPharma secures $85 million in Series A Financing
SAN DIEGO, May 14, 2018 -- (Healthcare Sales & Marketing Network) -- Ansun BioPharma, Inc., a leading biotechnology company focused on the development of novel broad spectrum anti-viral biologic therapeutics to combat severe viral respiratory tract infect... Biopharmaceuticals, Venture Capital, Personnel Ansun BioPharma, DAS181, parainfluenza (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - May 14, 2018 Category: Pharmaceuticals Source Type: news

Aquestive Therapeutics Settles Patent Infringement Case with Par Pharmaceuticals
WARREN, N.J., May 14, 2018 -- (Healthcare Sales & Marketing Network) -- Aquestive Therapeutics, Inc., today announced a settlement agreement has been reached resolving patent litigation related to SUBOXONE® (buprenorphine and naloxone) Sublingual Film... Biopharmaceuticals, Drug Delivery, Generics, Litigation Aquestive Therapeutics, Par Pharmaceuticals, SUBOXONE, buprenorphine, naloxo (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - May 14, 2018 Category: Pharmaceuticals Source Type: news

Immunicom's Immunotherapy Product Receives U.S. FDA Breakthrough Device Designation for the Treatment of Cancer
SAN DIEGO, May 14, 2018 -- (Healthcare Sales & Marketing Network) -- Immunicom, Inc., a medical technology company developing revolutionary non-pharmaceutical approaches for treating cancer and autoimmune diseases, has received Breakthrough Device designa... Devices, Oncology, FDA Immunicom, Immunopheresis (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - May 14, 2018 Category: Pharmaceuticals Source Type: news

Grifols Expands its Blood Typing Solutions Portfolio in the United States with Antisera Reagents
Grifols conventional antisera reagents recently received licensing approval by the U.S. Food & Drug Administration for manual testing in immunohematology laboratories The addition of antisera reagents completes Grifols full range of serological blood ty... Diagnostics, Product Launch Grifols, blood typing, antisera reagents (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - May 14, 2018 Category: Pharmaceuticals Source Type: news

GT Biopharma Announces Dr. Raymond W Urbanski Elevated to President and Chief Medical Officer of the Company
LOS ANGELES, May 14, 2018 -- (Healthcare Sales & Marketing Network) -- GT Biopharma Inc. (OTCQB: GTBP)(Euronext Paris GTBP.PA) today announced the promotion of Dr. Raymond W Urbanski MD, PhD to the position of President and Chief Medical Officer effective... Biopharmaceuticals, Oncology, Personnel GT Biopharma, Natural Killer Cell Engagers (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - May 14, 2018 Category: Pharmaceuticals Source Type: news

Lilly to Acquire AurKa Pharma
Acquisition Expands Lilly Oncology Pipeline with Early-Phase Asset Being Studied in Multiple Tumor Types INDIANAPOLIS, May 14, 2018 -- (Healthcare Sales & Marketing Network) -- Eli Lilly and Company (NYSE: LLY) today announced an agreement to acquire A... Biopharmaceuticals, Oncology, Mergers & Acquisitions Eli Lilly, AurKa Pharma, Aurora kinase A inhibitor (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - May 14, 2018 Category: Pharmaceuticals Source Type: news

Accomplished Global Pharmaceutical Executive, Federico Seghi Recli, Appointed To Titan's Board
SOUTH SAN FRANCISCO, Calif., May 14, 2018 -- (Healthcare Sales & Marketing Network) -- Titan Pharmaceuticals, Inc. (NASDAQ: TTNP), a company developing proprietary therapeutics for the treatment of select chronic diseases utilizing its ProNeura™ long-term... Biopharmaceuticals, Drug Delivery, Personnel Titan Pharmaceuticals, ProNeura, Probuphine (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - May 14, 2018 Category: Pharmaceuticals Source Type: news

CurveBeam Announces FDA 510(k) Clearance for LineUP Weight Bearing Multi-Extremity CT System
WARRINGTON, Pa., May 14, 2018 -- (Healthcare Sales & Marketing Network) -- CurveBeam announced it has received FDA 510(k) clearance for its LineUP Multi-extremity weight bearing CT system. The compact system enables radiologists and orthopedic speciali... Devices, Radiology, Orthopaedic, FDA CurveBeam, LineUP, CT , weight bearing CT (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - May 14, 2018 Category: Pharmaceuticals Source Type: news

FDA approves additional claim for Roche cobas Zika test
New claim allows for streamlined screening of pooled blood or plasma donations Approved claim follows updated industry recommendations for screening the US blood supply for Zika virus Zika virus infection is linked to neurological complications in ad... Diagnostics, FDA Roche Group, cobas Zika, Zika (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - May 14, 2018 Category: Pharmaceuticals Source Type: news

Cerus Endovascular Promotes Stephen Griffin, PhD, to President
Company On-Track to Achieve Key Clinical and Regulatory Milestones FREMONT, Calif. and OXFORD, England, May 11, 2018 -- (Healthcare Sales & Marketing Network) -- Cerus Endovascular Ltd., a privately-held, commercial-stage medical device company engaged... Devices, Interventional, Radiology, Neurology, Personnel Cerus Endovascular, Contour Neurovascular System, intracranial aneurysm (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - May 11, 2018 Category: Pharmaceuticals Source Type: news

Interpace Diagnostics Announces Expanded Coverage Among Blue Cross Blue Shield Plans
14 New Plans Cover ThyGenX® and ThyraMIR® in 2018 to Date PARSIPPANY, N.J., May 10, 2018 -- (Healthcare Sales & Marketing Network) -- Interpace Diagnostics Group, Inc. (NASDAQ:IDXG) (“Interpace” or “the Company”), a fully integrated commercial a... Diagnostics, Oncology, Reimbursement Interpace Diagnostics, ThyraMir, thyroid cancer, PancraGEN, pancreatic cancer (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - May 10, 2018 Category: Pharmaceuticals Source Type: news

Permira Funds To Acquire Corin A Leading Orthopaedic Company
New funding to fuel the next stage of Corin's development after 5 years of outstanding growth LONDON, May 10, 2018 -- (Healthcare Sales & Marketing Network) -- Global investment firm Permira and Corin Orthopaedics Holding Ltd ("Corin"), one o... Devices, Orthopaedic, Mergers & Acquisitions Corin Orthopaedics, Permira Funds (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - May 10, 2018 Category: Pharmaceuticals Source Type: news

Aldeyra Therapeutics Appoints David McMullin as Senior Vice President, Corporate Development and Strategy
LEXINGTON, Mass., May 10, 2018 -- (Healthcare Sales & Marketing Network) -- Aldeyra Therapeutics, Inc. (NASDAQ: ALDX) (Aldeyra), a biotechnology company devoted to development of next-generation medicines to improve the lives of patients with immune-media... Biopharmaceuticals, Ophthalmology, Personnel Aldeyra Therapeutics, reproxalap, conjunctivitis (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - May 10, 2018 Category: Pharmaceuticals Source Type: news

ReShape Lifesciences Announces Submission for Approval of ReShape Balloon(TM) in Canada
SAN CLEMENTE, Calif., May 10, 2018 -- (Healthcare Sales & Marketing Network) -- ReShape Lifesciences Inc. (NASDAQ: RSLS), a developer of minimally invasive medical devices to treat obesity and metabolic diseases, announced today the submission of an appli... Devices, Regulatory ReShape Lifesciences, ReShape Balloon, obesity (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - May 10, 2018 Category: Pharmaceuticals Source Type: news

Lilly Announces Agreement To Acquire ARMO BioSciences
$1.6 billion transaction will bolster Lilly's clinical portfolio with ARMO's lead immuno-oncology asset, pegilodecakin, which is being studied in multiple tumor types INDIANAPOLIS and REDWOOD CITY, Calif., May 10, 2018 -- (Healthcare Sales & Marketing N... Biopharmaceuticals, Oncology, Mergers & Acquisitions Eli Lilly, ARMO BioSciences, pegilodecakin (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - May 10, 2018 Category: Pharmaceuticals Source Type: news

Scapa Healthcare Introduces New Hydrocolloid Offerings for Ostomy Applications
Ready-to-Market Solutions Provide Secure Fixation of Ostomy Appliances on Sensitive Skin and Challenging Anatomical Areas WINDSOR, Conn., May 09, 2018 -- (Healthcare Sales & Marketing Network) -- Scapa Healthcare, a global strategic outsource partner of... Devices, Product Launch Scapa Healthcare, Soft-Pro, Hydrocolloid, Ostomy (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - May 9, 2018 Category: Pharmaceuticals Source Type: news

Adventus Ventures announces initial financing for several of its medical device portfolio companies
IRVINE, Calif., May 9, 2018 -- (Healthcare Sales & Marketing Network) -- Adventus Ventures, LLC, a medical device company incubator and early stage medical device VC, announced today that it has completed initial financing for several of its portfolio com... Devices, Venture Capital Adventus Ventures, Allevion therapeutics, Pressao Medical, Temari Medical (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - May 9, 2018 Category: Pharmaceuticals Source Type: news

DURECT Announces Amendment to Licensing Agreement with Sandoz Related to POSIMIR(R) (SABER(R)-Bupivacaine)
CUPERTINO, Calif., May 9, 2018 -- (Healthcare Sales & Marketing Network) -- DURECT Corporation (Nasdaq: DRRX) today announced it has entered into an amendment (the "Amendment") to the development and commercialization agreement with Sandoz AG, a... Biopharmaceuticals, Drug Delivery, Surgery, Licensing DURECT, Sandoz, Novartis, POSIMIR, bupivacaine (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - May 9, 2018 Category: Pharmaceuticals Source Type: news

Sensus Healthcare Appoints Dr. Isabelle Raymond as Vice President, Clinical Development
New Executive Leader Brings Extensive Clinical Research, Medical Marketing and Product Launch Experience to the Company BOCA RATON, Fla., May 8, 2018 -- (Healthcare Sales & Marketing Network) -- Sensus Healthcare, Inc. (NASDAQ: SRTS), a medical device ... Devices, Oncology, Dermatology, Personnel Sensus Healthcare, superficial radiation therapy, skin cancer (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - May 8, 2018 Category: Pharmaceuticals Source Type: news

Pliant Therapeutics Appoints Hoyoung Huh as Chairman and Éric Lefebvre as Chief Medical Officer
REDWOOD CITY, Calif., May 8, 2018 -- (Healthcare Sales & Marketing Network) -- Pliant Therapeutics, Inc., a company focused on discovering, developing and commercializing breakthrough treatments for fibrotic diseases, today announced that Hoyoung Huh, M.D... Biopharmaceuticals, Personnel Pliant Therapeutics, fibrosis (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - May 8, 2018 Category: Pharmaceuticals Source Type: news

Valeant Will Become Bausch Health Companies Inc.
Bausch Health Companies Inc. Accurately Represents the Breadth of the Company Today and Reflects the Innovative Legacy of the Bausch Name Name Change Will be Effective in July 2018 LAVAL, Quebec, May 8, 2018 -- (Healthcare Sales & Marketing Network) ... Biopharmaceuticals, Dermatology Valeant Pharmaceuticals, Bausch Health Companies (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - May 8, 2018 Category: Pharmaceuticals Source Type: news

Sciton Announces New Leadership Team
Results-Oriented Leadership Will Provide Fresh Strategic Direction Looking Into The Future PALO ALTO, Calif., May 8, 2018 -- (Healthcare Sales & Marketing Network) -- Sciton®, a leading manufacturer of high-quality laser and light systems in the ae... Devices, Dermatology, Personnel Sciton, laser-assisted lipolysis, skin resurfacing, phototherapy (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - May 8, 2018 Category: Pharmaceuticals Source Type: news

NRG(R) Transseptal Needle Associated with a 40% Lower Risk of Silent Cerebral Embolism
TORONTO, May 8, 2018 -- (Healthcare Sales & Marketing Network) - A recent study published in Heart and Vessels has found that the use of the Baylis Medical NRG® radiofrequency (RF) Transseptal Needle for transseptal punctures was linked to a 40% lower... Devices, Cardiology Baylis Medical, Transseptal Needle, NRG needle, atrial fibrillation, ablation (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - May 8, 2018 Category: Pharmaceuticals Source Type: news

TFF Pharmaceuticals Announces Appointment of Glenn Mattes as New Chief Executive Officer
AUSTIN, Texas, May 8, 2018 -- (Healthcare Sales & Marketing Network) -- TFF Pharmaceuticals, Inc., an early-stage biopharmaceutical company focused on developing and commercializing innovative drug products for the treatment of lung diseases and condition... Biopharmaceuticals, Drug Delivery, Personnel TFF Pharmaceuticals, Thin Film Freezing (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - May 8, 2018 Category: Pharmaceuticals Source Type: news